Wheeler Benjamin Richard 4

What Happened Benjamin R. Wheeler, Chief Financial Officer of Myriad Genetics (MYGN), had 549 shares of common stock withheld by the company to satisfy tax withholding obligations in connection with vested restricted stock units. The shares were valued at $4.58 each, for a total of approximately $2,514. This was a tax-withholding disposition (not an open-market sale).

Key Details

• Transaction date: March 22, 2026; filing date: March 23, 2026.
• Price per share: $4.58; total value of shares withheld: ~$2,514.
• Shares owned following the transaction: not specified in the filing.
• Footnote: The number of shares withheld was determined using the closing price of Myriad common stock on March 20, 2026 (per filing footnote F1).
• Transaction type/code: F — shares withheld to satisfy tax withholding on vested RSUs.
• Filing timeliness: Report filed one day after the transaction date; appears timely based on the filing and report dates.

Context This was a routine corporate tax-withholding action tied to the vesting of restricted stock units. Because the company withheld shares to cover tax obligations (a cashless withholding), it should not be interpreted the same way as an open-market sale by the insider and does not necessarily indicate a change in insider sentiment.